Lv3
360 积分 2023-05-07 加入
Covalent targeted radioligands potentiate radionuclide therapy
19天前
已完结
Respiratory delivery of single low-dose nebulized PFCE-C25 NEs for lymphatic transport and durable stimulation of antitumor immunity in lung cancer
21天前
已完结
Pulmonary delivery of nano‐particles for lung cancer diagnosis and therapy: Recent advances and future prospects
25天前
已完结
PD-L1 in NSCLC cytology
30天前
已完结
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types
30天前
已完结
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
30天前
已完结
Emerging biomarkers for immune checkpoint inhibition in lung cancer
30天前
已完结
PD-1 expression in tumor infiltrating lymphocytes as a prognostic marker in early-stage non-small cell lung cancer
30天前
已完结
Complete Resolution of Locally Advanced Prostate Cancer After Molecular Endoradiotherapy With 177Lu-PSMA
1个月前
已完结
Cerebral and Muscular Metastases From Prostate Adenocarcinoma Initially Depicted by 177Lu-PSMA SPECT/CT
1个月前
已完结
皖公网安备34019202002308
